Search

Search any products, services and so on here.

About 16311 result(s)

Global Tucatinib Tablets Market Research Report 2024

  • Sep 18, 24
  • ID: 553574
  • Pages: 71
  • Figures: 72
  • Views: 0
  • From $2,900

Tucatinib tablets are a type of medication used in the treatment of certain types of breast cancer.Tucatinib tablets are typically prescribed for patients with HER2-positive breast cancer, particularly in cases where the cancer has metastasized or is advanced. The global Tucatinib Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of...


Global Polidocanol Injection Market Research Report 2024

  • Sep 18, 24
  • ID: 553572
  • Pages: 78
  • Figures: 83
  • Views: 0
  • From $2,900

Polidocanol injection is a therapeutic drug primarily used in sclerotherapy to address varicose veins and spider veins. The global Polidocanol Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for Polidocanol Injection is estimated to increase from $ million in 2023...


Global Topiramate Tablets Market Research Report 2024

  • Sep 18, 24
  • ID: 553571
  • Pages: 90
  • Figures: 90
  • Views: 0
  • From $2,900

Topiramate tablets are oral medications containing topiramate, a versatile drug used primarily for the treatment of epilepsy and the prevention of migraines. The global Topiramate Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for Topiramate Tablets is estimated to...


Global Topiramate Drugs Market Research Report 2024

  • Sep 18, 24
  • ID: 553570
  • Pages: 117
  • Figures: 109
  • Views: 0
  • From $2,900

Topiramate drugs refer to medications containing topiramate, which is used to treat various neurological conditions, including epilepsy and migraine headaches.These drugs are usually administered orally in tablet or capsule form. The global Topiramate Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 202...


Global Sacubitril Valsartan Sodium Drugs Market Research Report 2024

  • Sep 18, 24
  • ID: 553569
  • Pages: 107
  • Figures: 98
  • Views: 0
  • From $2,900

Sacubitril/valsartan sodium drugs refer to medications that combine two active ingredients, sacubitril and valsartan, used primarily for treating heart failure. The global Sacubitril Valsartan Sodium Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for Sacubitril Valsart...


Global Sacubitril Valsartan Sodium Tablets Market Research Report 2024

  • Sep 18, 24
  • ID: 553568
  • Pages: 101
  • Figures: 98
  • Views: 0
  • From $2,900

Sacubitril/valsartan sodium tablets are a combination medication used primarily in the treatment of heart failure. This drug pairs two active ingredients: sacubitril, which is a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker (ARB). The global Sacubitril Valsartan Sodium Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnes...


Global Enzalutamide Soft Capsules Market Research Report 2024

  • Sep 18, 24
  • ID: 553567
  • Pages: 90
  • Figures: 92
  • Views: 0
  • From $2,900

Enzalutamide soft capsules are an oral medication used in the treatment of metastatic castration-resistant prostate cancer. Each soft capsule contains the active ingredient enzalutamide, a potent androgen receptor inhibitor that works by inhibiting the action of androgens (such as testosterone) on prostate cancer cells. The global Enzalutamide Soft Capsules market was valued at US$ million in 202...


Global Enzalutamide Drugs Market Research Report 2024

  • Sep 18, 24
  • ID: 553566
  • Pages: 105
  • Figures: 106
  • Views: 0
  • From $2,900

Enzalutamide drugs are medications that contain enzalutamide, an androgen receptor inhibitor that works by blocking the effects of androgens (male hormones like testosterone) on cancer cells. The global Enzalutamide Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for E...


Global Thymalfasin Drugs Market Research Report 2024

  • Sep 18, 24
  • ID: 553564
  • Pages: 105
  • Figures: 105
  • Views: 0
  • From $2,900

Thymalfasin drugs refer to medications that contain thymalfasin, a synthetic form of thymosin alpha 1, a peptide with immunomodulatory properties.Thymalfasin is used in the treatment of various conditions, including chronic viral infections like hepatitis B and C, as well as certain cancers. The global Thymalfasin Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ milli...


Global Teneligliptin Hydrobromide API Market Research Report 2024

  • Sep 18, 24
  • ID: 553495
  • Pages: 74
  • Figures: 69
  • Views: 0
  • From $2,900

Tenegliptin hydrobromide is a drug used to treat type 2 diabetes. Teneligliptin Hydrobromide belongs to the category of medicines called "anti-diabetic" primarily used to treat type 2 diabetes, especially in persons whose sugar levels are too high and cannot be controlled by dieting and exercising. It is used alone or in combination with other drugs to lower blood sugar levels. The global Teneligl...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232